|
| Exchange Disseminated Time | Jubilant Life Sciences Ltd has informed BSE that Jubilant Pharma Limited ("JPL"), a Singapore company and wholly-owned subsidiary of Jubilant Life Sciences Limited, through Jubilant Generics Inc., a Delaware corporation and an indirect wholly-owned subsidiary of JPL, ("Jubilant Generics") has commenced a Tender Offer to acquire all outstanding shares of common stock (collectively, the "Shares") of Cadista Holdings Inc., a Delaware corporation ("Cadista"), not currently owned by JPL or its subsidiary companies (the "Tender Offer"). As of the date of this letter, JPL, through Jubilant Pharma Holdings Inc., a Delaware company and wholly-owned subsidiary of JPL, currently holds approximately 82.4% of the outstanding shares of common stock of Cadista. The Tender Offer transaction is being conducted in accordance with the federal laws of the United
States and the state law of Delaware. |
|
|